These data suggest that SIRPA reduces infection by viruses that require trafficking to acidic endosomes (NWAs, OWAs, VSV, ZIKV, EBOV), but not viruses that fuse at the plasma membrane (MLV, HSV-1) or whose entry is pH-independent (mNoV). The gene discussed is SIRPA; the disease is infection.